Why GeneDx Holdings Stock Just Dropped 16.6%
GeneDx met Wall Street's revenue target but missed on test volume and trimmed its volume growth outlook, and a stock priced on growth is paying for it.
Full story
Read the full story at The Motley Fool ↗
Continue reading this story on The Motley Fool, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.